MedTrace Logo

Treatment of IPF With Laparoscopic Anti-Reflux Surgery

NCT01982968 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2021-10-25

Study results available
· View outcomes & findings →

Summary

This study will test the hypothesis that treatment with laparoscopic anti-reflux surgery in subjects with idiopathic pulmonary fibrosis (IPF) and abnormal gastroesophageal reflux (GER) will slow the decline of forced vital capacity (FVC) over 48 weeks.

Conditions

Interventions

PROCEDURE

Surgery

Full fundoplication surgery for the treatment of abnormal GER

Sponsors & Collaborators

Principal Investigators

  • Harold R Collard, MD · University of California, San Francisco

  • Ganesh Raghu, MD · University of Washington

  • Kevin J Anstrom, PhD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01982968 on ClinicalTrials.gov